Buy Trovagene Stock | TROV Stock Price & Latest News | Public.com
TROV

Trovagene

$0.00 (0.00%)Today
    View Trovagene (TROV) stock trends here

    About TROV

    Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.13
    -0.19
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.16

    Actual EPS
    Q2 2021

    Stats

    Market Cap$306,79M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$25.50
    1 Year Low$0.83
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app